According to Vericel 's latest financial reports the company's total debt is $88.04 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $88.04 M | 85.08% |
2022-12-31 | $47.57 M | -5.21% |
2021-12-31 | $50.18 M | -5.85% |
2020-12-31 | $53.3 M | 91.35% |
2019-12-31 | $27.85 M | |
2018-12-31 | $N/A | -100% |
2017-12-31 | $17.23 M | 70.18% |
2016-12-31 | $10.12 M | 14166.2% |
2015-12-31 | $0.07 M | -34.86% |
2014-12-31 | $0.1 M | 1716.67% |
2013-12-31 | $0 M | -85% |
2012-12-31 | $0.04 M | -50% |
2011-12-31 | $0.08 M | -68.63% |
2010-12-31 | $0.25 M | |
2010-06-30 | $0.3 M | -61.1% |
2009-06-30 | $0.78 M | -36.21% |
2008-06-30 | $1.22 M | -19.99% |
2007-06-30 | $1.53 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Royalty Pharma RPRX | $6.13 B | 6,868.52% | ๐ฌ๐ง UK |
Neogen NEOG | $0.89 B | 911.07% | ๐บ๐ธ USA |